Sold out but wanted!
More about the book
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Book purchase
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Language
- Released
- 2017
- product-detail.submit-box.info.binding
- (Paperback)
We’ll email you as soon as we track it down.
Payment methods
We’re missing your review here.
- Title
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Language
- English
- Authors
- Andrew Matthews, Frank S. David, Seth Robey
- Publisher
- Pharmagellan
- Released
- 2017
- Format
- Paperback
- Pages
- 138
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Series
- Rating
- 4.3 out of 5
- Description
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.